ZhuZhou QianJin Pharmaceutical Co Ltd (600479) - Total Liabilities
Based on the latest financial reports, ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has total liabilities worth CN¥1.70 Billion CNY (≈ $248.69 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of ZhuZhou QianJin Pharmaceutical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
ZhuZhou QianJin Pharmaceutical Co Ltd - Total Liabilities Trend (2001–2025)
This chart illustrates how ZhuZhou QianJin Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 600479 current and non-current assets.
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of ZhuZhou QianJin Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mega Lifesciences Public Company Limited
BK:MEGA
|
Thailand | ฿4.37 Billion |
|
Upbound Group Inc.
NASDAQ:UPBD
|
USA | $2.37 Billion |
|
Yotrio Group Co Ltd
SHE:002489
|
China | CN¥2.81 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$4.44 Billion |
|
Malion New Materials Co Ltd
SHE:300586
|
China | CN¥1.79 Billion |
|
Mcmillan Shakespeare Ltd
AU:MMS
|
Australia | AU$1.37 Billion |
|
Tianjin Printronics Circuit Corp
SHE:002134
|
China | CN¥1.57 Billion |
|
Bajaj Mobility AG
VI:BMAG
|
Austria | €1.20 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down ZhuZhou QianJin Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of ZhuZhou QianJin Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ZhuZhou QianJin Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ZhuZhou QianJin Pharmaceutical Co Ltd (2001–2025)
The table below shows the annual total liabilities of ZhuZhou QianJin Pharmaceutical Co Ltd from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.61 Billion ≈ $236.11 Million |
+13.86% |
| 2024-12-31 | CN¥1.42 Billion ≈ $207.37 Million |
-14.12% |
| 2023-12-31 | CN¥1.65 Billion ≈ $241.47 Million |
-9.21% |
| 2022-12-31 | CN¥1.82 Billion ≈ $265.97 Million |
+33.61% |
| 2021-12-31 | CN¥1.36 Billion ≈ $199.06 Million |
-7.26% |
| 2020-12-31 | CN¥1.47 Billion ≈ $214.63 Million |
+24.03% |
| 2019-12-31 | CN¥1.18 Billion ≈ $173.05 Million |
+13.44% |
| 2018-12-31 | CN¥1.04 Billion ≈ $152.55 Million |
-0.31% |
| 2017-12-31 | CN¥1.05 Billion ≈ $153.02 Million |
+10.28% |
| 2016-12-31 | CN¥948.21 Million ≈ $138.75 Million |
+21.70% |
| 2015-12-31 | CN¥779.17 Million ≈ $114.02 Million |
-7.59% |
| 2014-12-31 | CN¥843.20 Million ≈ $123.39 Million |
+23.29% |
| 2013-12-31 | CN¥683.92 Million ≈ $100.08 Million |
+17.68% |
| 2012-12-31 | CN¥581.18 Million ≈ $85.04 Million |
+101.73% |
| 2011-12-31 | CN¥288.10 Million ≈ $42.16 Million |
+52.71% |
| 2010-12-31 | CN¥188.65 Million ≈ $27.61 Million |
-40.01% |
| 2009-12-31 | CN¥314.48 Million ≈ $46.02 Million |
+71.23% |
| 2008-12-31 | CN¥183.66 Million ≈ $26.87 Million |
-2.98% |
| 2007-12-31 | CN¥189.30 Million ≈ $27.70 Million |
+11.93% |
| 2006-12-31 | CN¥169.13 Million ≈ $24.75 Million |
-16.84% |
| 2005-12-31 | CN¥203.38 Million ≈ $29.76 Million |
+37.06% |
| 2004-12-31 | CN¥148.38 Million ≈ $21.71 Million |
-21.17% |
| 2003-12-31 | CN¥188.23 Million ≈ $27.54 Million |
+7.98% |
| 2002-12-31 | CN¥174.31 Million ≈ $25.51 Million |
-4.66% |
| 2001-12-31 | CN¥182.84 Million ≈ $26.76 Million |
-- |
About ZhuZhou QianJin Pharmaceutical Co Ltd
ZhuZhou QianJin Pharmaceutical Co.,Ltd researches, develops, produces, and sells traditional Chinese medicines, chemicals and API, and TCM derivatives in China. The company offers TCM products, chemical medicine, derivative products, and hygienic products, including gynaecological and baby nursing, and maternity pad/ maternity package. ZhuZhou QianJin Pharmaceutical Co.,Ltd was founded in 1966 an… Read more